Bengay Vanishing Scent

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Bengay Vanishing Scent
Generic name: MENTHOL, UNSPECIFIED FORM
Manufacturer: Kenvue Brands LLC
Product type: HUMAN OTC DRUG
SPL set ID: 6cc3294b-3b0f-44d0-af71-61db1022d269
SPL ID: 3990cb88-d01e-69b5-e063-6294a90af96d
Version: 8
Effective date: 2025-07-10
Source export date: 2026-10-27
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/35717de05250cd386420cc8ede3b6010b48d18eea2af59afb0617fcabca634ec/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:05:22

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Bengay Vanishing Scent	openfda.brand_name
generic name		MENTHOL, UNSPECIFIED FORM	openfda.generic_name
manufacturer name		Kenvue Brands LLC	openfda.manufacturer_name
ndc	package	69968-0595-2	openfda.package_ndc
ndc	product	69968-0595	openfda.product_ndc
ndc11	package	69968059502	derived:openfda.package_ndc
rxcui		282805	openfda.rxcui
spl id		3990cb88-d01e-69b5-e063-6294a90af96d	id
spl set id		6cc3294b-3b0f-44d0-af71-61db1022d269	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use on wounds or damaged skin with a heating pad on a child under 12 years of age with arthritis-like conditions Ask a doctor before use if you have redness over the affected area When using this product avoid contact with eyes or mucous membranes do not bandage tightly Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days symptoms clear up and occur again within a few days excessive skin irritation occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.